128 related articles for article (PubMed ID: 7654075)
1. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?
Kish SJ; Zhong XH; Hornykiewicz O; Haycock JW
Ann Neurol; 1995 Aug; 38(2):260-4. PubMed ID: 7654075
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
[TBL] [Abstract][Full Text] [Related]
3. Striatal 18F-dopa uptake: absence of an aging effect.
Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Cordes M; Snow BJ; Cooper S; Schulzer M; Pate BD; Ruth TJ; Calne DB
Ann Neurol; 1994 Oct; 36(4):667-70. PubMed ID: 7944302
[TBL] [Abstract][Full Text] [Related]
5. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
[TBL] [Abstract][Full Text] [Related]
6. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
Kuwabara H; Cumming P; Reith J; Léger G; Diksic M; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1993 Jan; 13(1):43-56. PubMed ID: 8417009
[TBL] [Abstract][Full Text] [Related]
7. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
8. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
Sawle GV; Playford ED; Burn DJ; Cunningham VJ; Brooks DJ
Arch Neurol; 1994 Mar; 51(3):237-43. PubMed ID: 8129633
[TBL] [Abstract][Full Text] [Related]
9. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
Ernst M; Zametkin AJ; Matochik JA; Pascualvaca D; Jons PH; Cohen RM
Am J Psychiatry; 1999 Aug; 156(8):1209-15. PubMed ID: 10450262
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.
Hu XS; Okamura N; Arai H; Higuchi M; Matsui T; Tashiro M; Shinkawa M; Itoh M; Ido T; Sasaki H
Neurology; 2000 Nov; 55(10):1575-7. PubMed ID: 11094120
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
Sawle GV; Bloomfield PM; Björklund A; Brooks DJ; Brundin P; Leenders KL; Lindvall O; Marsden CD; Rehncrona S; Widner H
Ann Neurol; 1992 Feb; 31(2):166-73. PubMed ID: 1575455
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Turjanski N; Lees AJ; Brooks DJ
Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
[TBL] [Abstract][Full Text] [Related]
13. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
[TBL] [Abstract][Full Text] [Related]
14. Striatal function in normal aging: implications for Parkinson's disease.
Sawle GV; Colebatch JG; Shah A; Brooks DJ; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Dec; 28(6):799-804. PubMed ID: 2126684
[TBL] [Abstract][Full Text] [Related]
15. Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease.
Menza MA; Mark MH; Burn DJ; Brooks DJ
J Neuropsychiatry Clin Neurosci; 1995; 7(2):176-9. PubMed ID: 7626960
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic dopaminergic function in the striatum of schizophrenic patients.
Dao-Castellana MH; Paillère-Martinot ML; Hantraye P; Attar-Lévy D; Rémy P; Crouzel C; Artiges E; Féline A; Syrota A; Martinot JL
Schizophr Res; 1997 Feb; 23(2):167-74. PubMed ID: 9061812
[TBL] [Abstract][Full Text] [Related]
17. Nigrostriatal function in humans studied with positron emission tomography.
Martin WR; Palmer MR; Patlak CS; Calne DB
Ann Neurol; 1989 Oct; 26(4):535-42. PubMed ID: 2510586
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine.
Deep P; Dagher A; Sadikot A; Gjedde A; Cumming P
Synapse; 1999 Dec; 34(4):313-8. PubMed ID: 10529725
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
McGowan S; Lawrence AD; Sales T; Quested D; Grasby P
Arch Gen Psychiatry; 2004 Feb; 61(2):134-42. PubMed ID: 14757589
[TBL] [Abstract][Full Text] [Related]
20. The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.
Pate BD; Snow BJ; Hewitt KA; Morrison KS; Ruth TJ; Calne DB
J Nucl Med; 1991 Jun; 32(6):1246-51. PubMed ID: 1904482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
